Novavax Inc. Stock Falls Friday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) slipped 5.44% to $19.66 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 0.01% to 11,146.06 and the Dow Jones Industrial Average rising 0.59% to 33,745.69. This was the stock's third consecutive day of losses. Novavax Inc. closed $216.84 short of its 52-week high ($236.50), which the company achieved on December 20th.
The stock underperformed when compared to some of its competitors Friday, as Replimune Group Inc. (REPL) fell 2.36% to $19.03, VBI Vaccines Inc. (VBIV) fell 2.71% to $0.61, and AnaptysBio Inc. (ANAB) fell 3.16% to $27.28. Trading volume (3.6 M) remained 1.6 million below its 50-day average volume of 5.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 18, 2022.
(END) Dow Jones Newswires
November 18, 2022 17:13 ET (22:13 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.